5'-adenylyl (beta,gamma-methylene)diphosphonate has been researched along with Metabolic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, M; Kagota, S; Kubota, Y; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tanaka, N; Yamamoto, R | 1 |
1 other study(ies) available for 5'-adenylyl (beta,gamma-methylene)diphosphonate and Metabolic Syndrome
Article | Year |
---|---|
Dysfunction of purinergic regulation of sympathetic neurotransmission in SHR/NDmcr-cp (SHR-cp) rat.
Topics: 2-Chloroadenosine; Adenosine Triphosphate; Animals; Arteries; Electric Stimulation; In Vitro Techniques; Male; Metabolic Syndrome; Norepinephrine; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Receptors, Purinergic P2; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 2004 |